-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RbyOJIkx5Zkaqz4q08EpdtOABgn1Jy7pYH28VB7mrA/nvEuNCf7ByqApDzNXsy5A SRacKcUS5K+hdJrSDLaABg== 0000903112-00-000223.txt : 20000308 0000903112-00-000223.hdr.sgml : 20000308 ACCESSION NUMBER: 0000903112-00-000223 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20000210 FILED AS OF DATE: 20000307 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DISCOVERY LABORATORIES INC /DE/ CENTRAL INDEX KEY: 0000946486 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171943 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: SEC FILE NUMBER: 000-26422 FILM NUMBER: 562788 BUSINESS ADDRESS: STREET 1: 350 MAIN STREET SUITE 307 CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 2152404699 MAIL ADDRESS: STREET 1: 350 MAIN STREET SUITE 307 CITY: DOYLESTOWN STATE: PA ZIP: 18901 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 19961121 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN INC DATE OF NAME CHANGE: 19950609 COMPANY DATA: COMPANY CONFORMED NAME: CAPETOLA ROBERT J CENTRAL INDEX KEY: 0001067985 STANDARD INDUSTRIAL CLASSIFICATION: [] OFFICER FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: DISCOVERY LABORATORIES INC STREET 2: 3359 DURHAM RD CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 2157943064 MAIL ADDRESS: STREET 1: DISCOVERY LABORATORIES INC STREET 2: 3359 DURHAM RD CITY: DOYLESTOWN STATE: PA ZIP: 18901 4 1 FORM 4 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP [_] Check box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 1. Name and Address of Reporting Person (If the Form is filed by more than one Reporting Person, see Instruction 4(b)(v).) Capetola, Robert J. (Last) (First) (Middle) 6097 Hidden Valley Drive (Street) Doylestown, PA 18901 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Discovery Laboratories, Inc. (Discovery) DSCO 3. IRS or Social Security Number of Reporting Person (Voluntary) 4. Statement for (Month/Year) 02/2000 5. If Amendment, Date of Original (Month/Year) 6. Relationship of Reporting Person to Issuer (Check all applicable) X Director X 10% Owner --- --- X Officer (give title below) Other (specify below) --- --- 7. Individual or Joint/Group Filing (Check applicable line) X Form filed by One Reporting Person --- Form filed by More than One Reporting Person --- Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
6. 4. 5. Owner- Securities Acquired (A) or Amount of ship 3. Disposed of (D) Securities Form: 7. Transaction (Instr. 3, 4 and 5) Beneficially Direct Nature of 2. Code ------------------------------- Owned at End (D) or Indirect 1. Transaction (Instr. 8) (A) of Month Indirect Beneficial Title of Security Date ------------ Amount or Price (Instr. 3 (I) Ownership (Instr. 3) (mm/dd/yy) Code V (D) and 4) (Instr.4) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 02/10/00 M 62,500 A $1.38 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 02/10/00 F 16,234 D $5.3125(1) 507,346(2) D - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------
(1) Represents the market price on the date of transfer of shares to Discovery Laboratories Inc. (2) Excludes 543,863 shares of Common Stock issuable on exercised of employee stock options previously listed in Table 1 as beneficially owned by Mr. Capetola which are not required to be listed in Table 1 pursuant to Instruction 4(c)(i). 3 Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 2. Conver- 5. sion Number of or Derivative 6. Exer- 4. Securities Date cise 3. Trans- Acquired (A) Exercisable and Price Trans- action or Disposed Expiration Date 1. of action Code of(D) (Month/Day/Year) Title of Deriv- Date (Instr. (Instr. 3, ---------------- Derivative ative (Month/ 8) 4 and 5) Date Expira- Security Secur- Day/ ------ ------------ Exer- tion (Instr. 3) ity Year) Code V (A) (D) cisable Date - ------------------------------------------------------------------------------ Employee stock $1.38 02/10/00 M 62,500 Immediately 9/30/09 option (right (2) to purchase) - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- (2) The remaining shares subject to the option are subject to repurchase by Discovery upon the occurrence of certain events relating to the market price of the common stock of Discovery, the failure of Discovery to enter into certain collaboration agreements or a sale or merger of Discovery. 4 10. 9. Owner- Number ship of Form Deriv- of 7. ative Deriv- 11. Title and Amount Secur- ative Nature of Underlying 8. ities Secur- of Securities Price Bene- ity: In- (Instr. 3 and 4) of ficially Direct direct ---------------- Deriv- Owned (D) or Bene- 1. Amount ative at End In- ficial Title of or Secur- of direct Owner- Derivative Number ity Month (I) ship Security of (Instr. (Instr. (Instr. (Instr. (Instr. 3) Title Shares 5) 4) 4) 4) - -------------------------------------------------------------------------- Employee stock Common Stock, 125,000 62,500 D option (right par value to purchase) $.001 per share Explanation of Responses: By:/s/ Robert Capetola March 7, 2000 **Signature of Reporting Person Date ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. 5
-----END PRIVACY-ENHANCED MESSAGE-----